Home > National Drug Code (NDC) > Rhizopus oryzae

Rhizopus oryzae - 36987-2079-4 - (Rhizopus oryzae)

Alphabetical Index


Drug Information of Rhizopus oryzae

Product NDC: 36987-2079
Proprietary Name: Rhizopus oryzae
Non Proprietary Name: Rhizopus oryzae
Active Ingredient(s): .05    g/mL & nbsp;   Rhizopus oryzae
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Rhizopus oryzae

Product NDC: 36987-2079
Labeler Name: Nelco Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA102192
Marketing Category: BLA
Start Marketing Date: 19720829

Package Information of Rhizopus oryzae

Package NDC: 36987-2079-4
Package Description: 50 mL in 1 VIAL, MULTI-DOSE (36987-2079-4)

NDC Information of Rhizopus oryzae

NDC Code 36987-2079-4
Proprietary Name Rhizopus oryzae
Package Description 50 mL in 1 VIAL, MULTI-DOSE (36987-2079-4)
Product NDC 36987-2079
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Rhizopus oryzae
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 19720829
Marketing Category Name BLA
Labeler Name Nelco Laboratories, Inc.
Substance Name RHIZOPUS ARRHIZUS VAR. ARRHIZUS
Strength Number .05
Strength Unit g/mL
Pharmaceutical Classes Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Rhizopus oryzae


General Information